Log in to search using one of your social media accounts:

 

Schizophrenia patients may be helped by talking to ‘avatar’
An experimental therapy involving patients with schizophrenia interacting with a computer-generated character that embodies one of the voices they hear, can help rapidly reduce symptoms, according to a new UK study. (Source: Nursing Times)
Source: Nursing Times - November 24, 2017 Category: Nursing Source Type: news

'I'm not going to listen to you anymore'
How avatar therapy is helping people stand up to schizophrenic voices by giving them a face. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 24, 2017 Category: Consumer Health News Source Type: news

'I'm not going to listen to you any more'
How avatar therapy is helping people stand up to schizophrenic voices by giving them a face. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 24, 2017 Category: Consumer Health News Source Type: news

Avatar therapy 'reduces power of schizophrenia voices'
Patients became less distressed and heard voices less often compared with those who had counselling. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 24, 2017 Category: Consumer Health News Source Type: news

Avatars can help schizophrenia patients control threatening voices
LONDON, Nov 23 (Reuters) - - An experimental therapy for people with schizophrenia that brings them face to face with a computer avatar representing the tormenting voices in their heads has proved promising in early stage trials. (Source: Reuters: Health)
Source: Reuters: Health - November 23, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

'Avatar therapy' aims to help those who hear voices
People who hear voices, many living with schizophrenia, used computer-generated avatars to talk back, according to a new study. (Source: CNN.com - Health)
Source: CNN.com - Health - November 23, 2017 Category: Consumer Health News Source Type: news

Healthy body, healthy mind: a new approach for mental disorders - Science Weekly podcast
What role might the immune system play in mental illness? And how might this challenge long-held beliefs about the divide between body and brain?Subscribe& Review oniTunes,Soundcloud,Audioboom,Mixcloud&Acast, and join the discussion onFacebook andTwitterEarlier this month, a clinical trial began to test aradical new approach for treating schizophrenia. The trial comes from a team of scientists based in London who have discovered intriguing evidence that schizophrenia could be a disease of the immune system. But how could disruptions in the immune system lead to the kind of symptoms seen in schizophrenia? And might ...
Source: Guardian Unlimited Science - November 22, 2017 Category: Science Authors: Presented by Hannah Devlin and produced by Max Sanderson Tags: Science Schizophrenia Mental health Psychiatry Medicine Alzheimer's Society Source Type: news

Schizophrenia drug development may be 'de-risked' with new research tool
(Columbia University Medical Center) Researchers have identified biomarkers that can help with development of better treatments for schizophrenia. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 22, 2017 Category: International Medicine & Public Health Source Type: news

Self-Inflicted Injuries Surge Among Tween & Early Teen Girls
By Susan Scutti, CNN (CNN) — Emergency room visits for non-fatal, self-inflicted injuries surged in recent years among US girls and young women, especially those between the ages of 10 and 14, according to a new study. However, rates of self-harm among boys and young men between the ages of 10 and 24 remained stable throughout the years 2001 through 2015, the researchers said. “Suicide is preventable,” said Melissa C. Mercado, lead author of the study published Tuesday in JAMA and a behavioral scientist at the US Centers for Disease Control and Prevention. “These findings underscore the need for the...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 21, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN Suicide Source Type: news

Your NEJM Group Today: Diuretic Treatment in HF / Treatment-Resistant Schizophrenia? / Montana Internist/Hospitalist Opportunities
Have a look at what we've selected for you today: NEJM Clinical Practice Center: Review: This review discusses current pharmacologic principles of diuretic therapy, integrates... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 20, 2017 Category: Primary Care Source Type: news

In-Depth: How digital sensors could change the face of pharma
Earlier this week, Proteus Digital Health and Otsuka Pharmaceuticals announced that Abilify MyCite, a new, sensor-enabled version of Otsuka ’s drug for schizophrenia, had received FDA approval for mental health conditions including schizophrenia and bipolar disorder. (Source: mobihealthnews)
Source: mobihealthnews - November 17, 2017 Category: Information Technology Source Type: news

Reduced dorsolateral prefrontal cortex activation during affective Go/NoGo in violent schizophrenia patients: an fMRI study - Tik àsz A, Potvin S, Richard-Devantoy S, Lipp O, Hodgins S, Lalonde P, Lungu O, Dumais A.
We investigated the influence of anger processing on cognitive control in male schizophrenia patients presenting violent behaviors. We recruited 23 patients without and 24 patients with (SCZ+V) a history of violent behaviors, as well as 22 healthy non-viol... (Source: SafetyLit)
Source: SafetyLit - November 16, 2017 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Otsuka, Proteus finally win FDA approval for sensor-equipped Abilify
The first drug in the US with a digital ingestion tracking system has been approved by the FDA. The pill, Abilify MyCite, is prescribed for treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and as an add-on treatment for depression in adults. (Source: mobihealthnews)
Source: mobihealthnews - November 14, 2017 Category: Information Technology Source Type: news

FDA approves first trackable pill that syncs with a phone
The FDA approved a pill that tracks when patients take their prescribed psychiatric drug. The medication, Abilify MyCite, is a variation on a drug used to treat schizophrenia and bipolar disorder. (Source: the Mail online | Health)
Source: the Mail online | Health - November 14, 2017 Category: Consumer Health News Source Type: news

'Digital Pill' Lets Doctors Know It's Been Taken
The U.S. Food and Drug Administration has given the nod to Abilify MyCite, for use in patients with schizophrenia, an add-on treatment for depression, and to help control episodes of either manic or "mixed" episodes for people with bipolar disorder. (Source: WebMD Health)
Source: WebMD Health - November 14, 2017 Category: Consumer Health News Source Type: news

FDA OKs First 'Digital Pill' That Lets Doctors Know It's Been Taken
The U.S. Food and Drug Administration has given the nod to Abilify MyCite, for use in patients with schizophrenia, an add-on treatment for depression, and to help control episodes of either manic or "mixed" episodes for people with bipolar disorder. (Source: WebMD Health)
Source: WebMD Health - November 14, 2017 Category: Consumer Health News Source Type: news

FDA approves first pill with sensor to track ingestion
The FDA today approved Abilify MyCite, the first drug in the U.S. to have an ingestible sensor embedded within the pill that can track if the medication was taken. The drug-device combination product is indicated for the treatment of schizophrenia, acute treatment of manic and mixed episodes linked with bipolar I disorder and as an add-on treatment for depression in adults. Get the full story at our sister site, Drug Delivery Business News. The post FDA approves first pill with sensor to track ingestion appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - November 14, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Neurological Patient Monitoring Pharmaceuticals Regulatory/Compliance Wall Street Beat Otsuka Pharmaceutical Proteus Digital Health Source Type: news

FDA approves 'trackable' pill
The schizophrenia tablets have an embedded sensor that tells doctors whether the patient has taken them. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 14, 2017 Category: Consumer Health News Source Type: news

What support of young presenting a first psychotic episode, when schooling is being challenged? - Vacheron MN, Veyrat-Masson H, Wehbe E.
Psychiatric disorders (more specifically mood disorders and psychosis) represent the 1st cause of disability among young people. Unemployment rate between 75 to 95% for the person with schizophrenia. It is correlated to poor social integration and bad econ... (Source: SafetyLit)
Source: SafetyLit - November 14, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

First Digital Pill Approved to Worries About Biomedical ‘ Big Brother ’
The medicine, an antipsychotic drug, has a sensor that will show doctors whether and when patients are taking it. Other medicines will follow, experts say. (Source: NYT Health)
Source: NYT Health - November 14, 2017 Category: Consumer Health News Authors: PAM BELLUCK Tags: Mental Health and Disorders Sensors Drugs (Pharmaceuticals) Psychiatry and Psychiatrists Schizophrenia Food and Drug Administration Source Type: news

FDA approves pill with sensor that digitally tracks if patients have ingested their medication
The U.S. Food and Drug Administration today approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and for use as an add-on treatment for depression in adults. (Source: Food and Drug Administration)
Source: Food and Drug Administration - November 14, 2017 Category: American Health Source Type: news

FDA Approves Pill with Sensor that Digitally Tracks if Patients Have Ingested their Medication
The U.S. Food and Drug Administration has approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and for use as an add-on treatment for depression in adults. (Source: eHealth News EU)
Source: eHealth News EU - November 14, 2017 Category: Information Technology Tags: Featured Development Research and Development Source Type: news

FDA approves pill with sensor that digitally tracks if patients have ingested their medication
The U.S. Food and Drug Administration has approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and for use as an add-on treatment for depression in adults. (Source: World Pharma News)
Source: World Pharma News - November 14, 2017 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

Allergan Receives FDA Approval For Use of VRAYLAR(TM) (cariprazine) in the Maintenance Treatment of Schizophrenia
Label Expansion Includes New Data Showing Long-Term VRAYLAR Therapy Delayed Time to Relapse Compared to Placebo Over the Course of up to 72 Weeks DUBLIN, Nov. 13, 2017 -- (Healthcare Sales & Marketing Network) -- Allergan plc (NYSE: AGN) today announce... Biopharmaceuticals, Neurology, FDA Allergan, VRAYLAR, cariprazine, Schizophrenia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 13, 2017 Category: Pharmaceuticals Source Type: news

From the psychosis prodrome to the first-episode of psychosis: no evidence of a cognitive decline - Carri ón RE, Walder DJ, Auther AM, McLaughlin D, Zyla HO, Adelsheim S, Calkins R, Carter CS, McFarland B, Melton R, Niendam T, Ragland JD, Sale TG, Taylor SF, McFarlane WR, Cornblatt BA.
Cognitive deficits have an important role in the neurodevelopment of schizophrenia and other psychotic disorders. However, there is a continuing debate as to whether cognitive impairments in the psychosis prodrome are stable predictors of eventual psychosi... (Source: SafetyLit)
Source: SafetyLit - November 13, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Do cognitive deficits predict negative emotionality and aggression in schizophrenia? - Ahmed AO, Richardson J, Buckner A, Romanoff S, Feder M, Oragunye N, Ilnicki A, Bhat I, Hoptman MJ, Lindenmayer JP.
Schizophrenia is associated with an elevated risk of aggression. Cognitive deficits have been associated with inpatient aggression and future violence. The relationship between cognitive deficits and violent behavior has however been inconsistent across st... (Source: SafetyLit)
Source: SafetyLit - November 13, 2017 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Predictors of aggression in 3.322 patients with affective disorders and schizophrenia spectrum disorders evaluated in an emergency department setting - Blanco EA, Duque LM, Rachamallu V, Yuen E, Kane JM, Gallego JA.
INTRODUCTION: The aim of this study is to determine odds of aggression and associated factors in patients with schizophrenia-spectrum disorders (SSD) and affective disorders who were evaluated in an emergency department setting. METHODS: A retrospe... (Source: SafetyLit)
Source: SafetyLit - November 13, 2017 Category: International Medicine & Public Health Tags: Occupational Issues Source Type: news

Allergan Receives FDA Approval for Vraylar (cariprazine) in the Maintenance Treatment of Schizophrenia
DUBLIN, Nov. 13, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Vraylar (cariprazine) for the maintenance treatment of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 13, 2017 Category: Drugs & Pharmacology Source Type: news

Innovative genetic and cellular techniques help identify multiple disease targets
(Society for Neuroscience) Research released today highlights advances in the use of CRISPR-Cas9 and human induced pluripotent stem cell technologies to identify novel therapeutic targets for neurological disorders such as schizophrenia and addiction. The studies were presented at Neuroscience 2017, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 12, 2017 Category: Biology Source Type: news

Higher CRP, Lower Schizophrenia Risk? Higher CRP, Lower Schizophrenia Risk?
Increased levels of circulating C-reactive protein (CRP), an inflammatory biomarker, were associated with a reduced risk for schizophrenia in new findings that run contrary to previous research.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 9, 2017 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Genes May Explain Why Some Don't Respond to Bipolar Drug
WEDNESDAY, Nov. 8, 2017 -- In a finding that pulls the roots of two mental illnesses closer together, researchers say people with bipolar disorder that's resistant to the drug lithium have a high number of genes associated with schizophrenia. Since... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 8, 2017 Category: General Medicine Source Type: news

Gene breakthrough on lithium treatment for bipolar disorder
(University of Adelaide) Genes linked to schizophrenia in psychiatric patients suffering from bipolar disorder are the reason why such patients don't respond to the 'gold standard' treatment for bipolar -- the drug lithium -- according to international research led by the University of Adelaide. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 8, 2017 Category: International Medicine & Public Health Source Type: news

Helping Patients With Schizophrenia Review Their Lives, Imagine the Future Helping Patients With Schizophrenia Review Their Lives, Imagine the Future
Life Review Therapy helps patients with schizophrenia imagine themselves in the past and the future, new research suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 7, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

SlowMo, a digital therapy targeting reasoning in paranoia, versus treatment as usual in the treatment of people who fear harm from others: study protocol for a randomised controlled trial - Garety PA, Ward T, Freeman D, Fowler D, Emsley R, Dunn G, Kuipers E, Bebbington P, Waller H, Greenwood K, Rus-Calafell M, McGourty A, Hardy A.
BACKGROUND: Paranoia is one of the most common symptoms of schizophrenia-spectrum disorders, and is associated with significant distress and disruption to the person's life. Developing more effective and accessible psychological interventions for paranoia ... (Source: SafetyLit)
Source: SafetyLit - November 7, 2017 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Simple Skin Test May Help Identify Schizophrenia Simple Skin Test May Help Identify Schizophrenia
A niacin skin-flushing test may help identify patients with schizophrenia, new research shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 6, 2017 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Sustaining attention to simple visual tasks: a central deficit in schizophrenia? A systematic review - Hoonakker M, Doignon-Camus N, Bonnefond A.
Impairments in sustained attention, that is, the ability to achieve and maintain the focus of cognitive activity on a given stimulation source or task, have been described as central to schizophrenia. Today, sustained attention deficit is still considered ... (Source: SafetyLit)
Source: SafetyLit - November 6, 2017 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Growing Up with a Psychotic Mother
I was ten when my mother had her first psychotic break. It was May. I was looking forward to lazy summer days at the pool, an art camp, a stack of Babysitters Club books, and daydreaming about my first crush, a boy with a splay of freckles and a mop of dark hair. Instead, I was forced to grow up too soon. This meant wearing deodorant and shaving my arm pits. It also meant seeing my mother in a state of complete psychosis, one in which she thought maybe she had killed the postman or the neighbor girl. “I didn’t. Mean. Tokillthepostman.” Her words were all wrong, strung together in a series of hiccups a...
Source: Psych Central - November 6, 2017 Category: Psychiatry Authors: Leslie A. Lindsay Tags: Bipolar Depression Essays Family General Personal Stories Psychology Bipolar Disorder delusions hallucinations Hospitalization involuntary hospitalization Manic Depression Manic Episode Psychosis psychotic mania Source Type: news

Radical new approach to schizophrenia treatment begins trial
Exclusive: as evidence emerges that schizophrenia could be an immune system disease, two-year trial will use antibody drug currently used for MSBritish scientists have begun testing a radically new approach to treating schizophrenia based on emerging evidence that it could be adisease of the immune system.The first patient, a 33-year old man who developed schizophrenia after moving to London from Cameroon a decade ago, was treated at King ’s College Hospital in London on Thursday, marking the start of one of the most ambitious trials to date on the biology of the illness and how to treat it.Continue reading... (Sourc...
Source: Guardian Unlimited Science - November 3, 2017 Category: Science Authors: Hannah Devlin Science correspondent Tags: Schizophrenia Mental health Immunology Medical research Science Society Biology Source Type: news

Recognising that mind and body are not separate opens door for new treatments
As a trial for a radical schizophrenia treatment begins, the link between biological factors and some mental illnesses is becoming clearer than everDescartes ’s notion of dualism – that the mind and body are separate entities – is wrong, but has proved surprisingly persistent, and until recently dominated attempts to understand mental illness. When the brain stopped working properly, a psychological origin was sought.Undoubtedly, life ’s experiences and our personalities shape the way our brains function. But there is now a compelling body of evidence that brain disorders can also originate from thi...
Source: Guardian Unlimited Science - November 3, 2017 Category: Science Authors: Hannah Devlin Tags: Schizophrenia Immunology Science Mental health Society Medical research Source Type: news

New Cochrane Library Special Collection: Yoga for improving health and well-being
Yoga originated thousands of years ago in India as an integrated physical, mental, and spiritual practice based on ancient Vedic philosophy, and is connected to Ayurveda, the system of traditional Indian medicine. During the 20th century, yoga became increasingly recognised outside India, and over the past decades it has continued to grow in popularity worldwide as system for promoting health and well-being. While modern yoga often focuses on physical poses and is sometimes thought of as a type of exercise, the practice usually incorporates one or more of the mental or spiritual elements that are traditionally part of yoga...
Source: Cochrane News and Events - November 3, 2017 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Indian man who ate 639 nails is saved by doctors
A video captures the moment  doctors carried out an operation after the bizarre discovery. The 48-year-old schizophrenic patient in India regularly gobbled down nails and also eat soil. (Source: the Mail online | Health)
Source: the Mail online | Health - November 3, 2017 Category: Consumer Health News Source Type: news

Man eat 639 nails which doctors removed with a magnet
A video captures the moment  doctors carried out an operation after the bizarre discovery. The 48-year-old schizophrenic patient in India regularly gobbled down nails and also eat soil. (Source: the Mail online | Health)
Source: the Mail online | Health - November 3, 2017 Category: Consumer Health News Source Type: news

Scientists identify mechanism that helps us inhibit unwanted thoughts
(University of Cambridge) Scientists have identified a key chemical within the 'memory' region of the brain that allows us to suppress unwanted thoughts, helping explain why people who suffer from disorders such as anxiety, post-traumatic stress disorder (PTSD), depression, and schizophrenia often experience persistent intrusive thoughts when these circuits go awry. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 3, 2017 Category: International Medicine & Public Health Source Type: news

Aripiprazole May Reduce Cocaine Cravings in People With Schizophrenia Aripiprazole May Reduce Cocaine Cravings in People With Schizophrenia
In people with schizophrenia, the dopamine modulator aripiprazole appears to reduce cocaine cravings better than the dopamine blocker perphenazine after an acclimation period, according to a small, double-blind randomized trial.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 2, 2017 Category: Consumer Health News Tags: Psychiatry News Source Type: news

What effect has substance abuse on outcome of schizophrenia treated with antipsychotics?
(Bentham Science Publishers) Review in the journal Current Drug Abuse Reviews: Long-term administration of antipsychotics and the influence of drug abuse on the disease outcome (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 2, 2017 Category: International Medicine & Public Health Source Type: news

A high-coverage Neandertal genome from Vindija Cave in Croatia
To date, the only Neandertal genome that has been sequenced to high quality is from an individual found in Southern Siberia. We sequenced the genome of a female Neandertal from ~50,000 years ago from Vindija Cave, Croatia, to ~30-fold genomic coverage. She carried 1.6 differences per 10,000 base pairs between the two copies of her genome, fewer than present-day humans, suggesting that Neandertal populations were of small size. Our analyses indicate that she was more closely related to the Neandertals that mixed with the ancestors of present-day humans living outside of sub-Saharan Africa than the previously sequenced Neand...
Source: ScienceNOW - November 2, 2017 Category: Science Authors: Prüfer, K., de Filippo, C., Grote, S., Mafessoni, F., Korlevic, P., Hajdinjak, M., Vernot, B., Skov, L., Hsieh, P., Peyregne, S., Reher, D., Hopfe, C., Nagel, S., Maricic, T., Fu, Q., Theunert, C., Rogers, R., Skoglund, P., Chintalapati, M., Danne Tags: Anthropology, Genetics reports Source Type: news

MRI reveals brain changes caused by space travel
Long-term space travel causes changes in the brain anatomy of astronauts that...Read more on AuntMinnie.comRelated Reading: High-risk women not necessarily getting breast MRI DTI-MRI poses new cause for schizophrenia MRI could be 'game changer' for cardiac arrest survivors Deep learning can enable quantitative MRI for arthritis MRI detects cause of vision problems in astronauts (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 1, 2017 Category: Radiology Source Type: news

Hope of treating schizophrenia by tackling immune system
Patients who have been diagnosed with schizophrenia might actually be suffering from ‘immune malfunctions’ and could be treated with immunotherapy, an Oxford University study found. (Source: the Mail online | Health)
Source: the Mail online | Health - November 1, 2017 Category: Consumer Health News Source Type: news

Florida schizophrenic swallows a cigarette lighter
WARNING, GRAPHIC CONTENT: The anonymous patient, from Florida, suffered from schizophrenia and had a habit of swallowing strange objects, including a spoon. (Source: the Mail online | Health)
Source: the Mail online | Health - October 31, 2017 Category: Consumer Health News Source Type: news

Schizophrenic, 49, swallows a CIGARETTE LIGHTER
WARNING, GRAPHIC CONTENT: The anonymous patient, from Florida, suffered from schizophrenia and had a habit of swallowing strange objects, including a spoon. (Source: the Mail online | Health)
Source: the Mail online | Health - October 31, 2017 Category: Consumer Health News Source Type: news